Medical device firm Stent Tek said today it closed an undisclosed Series A financing round to support the development of its ePath AVF minimally invasive catheter technology.
The ePath AVF device is designed for vascular access as an alternative to surgical fistulas for hemodialysis patients.
Money in the round came from institutional investors Julz and Deepbridge Capital, the London-based company said.
Stent Tek has previously received $1.6 million (GBP £1.2 million) in grant funding from the National Institute of Health Research, Innovate UK and the Royal Academy of Engineering Enterprise Hub.
